Richard E Hanna DeceasedOak View, CA

Richard Hanna Phones & Addresses

Oak View, CA

La Mesa, CA

Soldotna, AK

Mentions for Richard E Hanna

Career records & work history

Lawyers & Attorneys

Richard Hanna Photo 1

Richard Hanna - Lawyer

ISLN:
906720590
Admitted:
1969
University:
Western Michigan University, B.A., 1966
Law School:
Wayne State University, J.D., 1969

Medicine Doctors

Richard C. Hanna

Specialties:
Orthopaedic Surgery
Work:
Kaiser Permanente Medical GroupKaiser Permanente Orthopedics
10800 Magnolia Ave BLDG 2 STE 136, Riverside, CA 92505
(951) 353-2000 (phone) (951) 353-4639 (fax)
Site
Education:
Medical School
Baylor College of Medicine
Graduated: 1997
Procedures:
Joint Arthroscopy, Shoulder Arthroscopy, Arthrocentesis, Knee Arthroscopy
Conditions:
Fractures, Dislocations, Derangement, and Sprains, Internal Derangement of Knee Cartilage, Internal Derangement of Knee Ligaments, Rotator Cuff Syndrome and Allied Disorders, Internal Derangement of Knee, Osteoarthritis
Languages:
English, Spanish
Description:
Dr. Hanna graduated from the Baylor College of Medicine in 1997. He works in Riverside, CA and specializes in Orthopaedic Surgery. Dr. Hanna is affiliated with Kaiser Permanente Riverside Medical Center.

Richard D. Hanna

Specialties:
Cardiovascular Disease
Work:
Mayo Clinic Health System In Eau Claire
1400 Bellinger St, Eau Claire, WI 54703
(715) 838-5222 (phone) (715) 838-6613 (fax)
Education:
Medical School
Medical College of Wisconsin School of Medicine
Graduated: 1989
Procedures:
Cardiac Stress Test, Cardioversion, Echocardiogram, Angioplasty, Cardiac Catheterization, Cardiac Rehabilitation, Continuous EKG, Electrocardiogram (EKG or ECG)
Conditions:
Aortic Valvular Disease, Atrial Fibrillation and Atrial Flutter, Cardiomyopathy, Abdominal Aortic Aneurysm, Acne, Acute Myocardial Infarction (AMI), Acute Renal Failure, Anemia, Angina Pectoris, Anxiety Dissociative and Somatoform Disorders, Anxiety Phobic Disorders, Aortic Aneurism, Aortic Regurgitation, Arterial Thromboembolic Disease, Atherosclerosis, Attention Deficit Disorder (ADD), Benign Paroxysmal Positional Vertigo, Cardiac Arrhythmia, Carditis, Chronic Renal Disease, Conduction Disorders, Congenital Anomalies of the Heart, Diabetes Mellitus (DM), Disorders of Lipoid Metabolism, Endocarditis, Epilepsy, Gastroesophageal Reflux Disease (GERD), Gastrointestinal Hemorrhage, Heart Failure, Hypertension (HTN), Hyperthyroidism, Inflammatory Bowel Disease (IBD), Iron Deficiency Anemia, Ischemic Heart Disease, Ischemic Stroke, Malignant Neoplasm of Female Breast, Mitral Stenosis, Mitral Valvular Disease, Obstructive Sleep Apnea, Osteoarthritis, Overweight and Obesity, Paroxysmal Supreventricular Tachycardia (PSVT), Pericardidtis, Pneumonia, Pulmonary Embolism, Rheumatoid Arthritis, Septicemia, Spinal Stenosis, Substance Abuse and/or Dependency, Systemic Lupus Erythematosus, Thoracid Aortic Aneurysm, Transient Cerebral Ischemia, Valvular Heart Disease, Venous Embolism and Thrombosis
Languages:
English
Description:
Dr. Hanna graduated from the Medical College of Wisconsin School of Medicine in 1989. He works in Eau Claire, WI and specializes in Cardiovascular Disease. Dr. Hanna is affiliated with Mayo Clinic Health System - Eau Claire, Mayo Clinic Health System Chippewa Valley Bloomer and Mayo Clinic Health System Northland.

License Records

Richard Curwin Hanna

Licenses:
License #: 6 - Expired
Category: Physical Therapy
Issued Date: Nov 20, 1957
Effective Date: Nov 2, 2001
Expiration Date: Nov 1, 2001
Type: Physical Therapist

Richard Hanna resumes & CV records

Resumes

Richard Hanna Photo 50

Founder | Chief Executive Officer

Location:
14707 199Th Ave, Bonney Lake, WA 98391
Industry:
Public Safety
Work:
Rhux Analytics
Founder | Chief Executive Officer
Lululemon Athletica
Web | Analytics| Testing Developer
Made Seattle Jul 2015 - Jul 2017
Front End Developer
Analytics Pros Jun 2017 - Jul 2017
Digital Analyst Intern
Analytics Pros Jun 2017 - Jul 2017
Developer + Digital Analyst
Service Master of Tacoma Aug 2016 - Jan 2017
Administrative Support
Smart Start, Inc. Nov 1, 2013 - Sep 2016
Assistant Service Manager
Uc San Diego Health Sep 2012 - May 2013
Patient Transport
Hellickson Real Estate Jul 2007 - Dec 2010
Property Inspections
Comcast Aug 2004 - Jul 2007
Inbound Sales
Education:
Hack Reactor 2016 - 2016
Treehouse 2015 - 2015
Green River College 2008 - 2010
Associates, Education
Home School
Skills:
Customer Service, Javascript, Sales, Python, Leadership, Social Networking, Swift, Team Building, Marketing, Team Leadership, Ios Development, Time Management, Marketing Communications, Management, New Business Development, React.js, Redux.js, Data Analysis, Typescript, Google Api, Restful Architecture, Google Analytics, Sql, Google Cloud Platform, Jquery, Angular5, Google Gcp, Google Website Optimizer, A/B Testing, Attribution Modeling, Google App Engine, Optimizely, Tealium, Ensighten
Interests:
Children
Richard Hanna Photo 51

Richard Hanna

Richard Hanna Photo 52

Richard Hanna

Richard Hanna Photo 53

Richard Hanna

Richard Hanna Photo 54

Richard J Hanna

Richard Hanna Photo 55

Richard Hanna

Richard Hanna Photo 56

Richard Hanna

Richard Hanna Photo 57

Richard Hanna

Publications & IP owners

Wikipedia

Richard Hanna Photo 66

Richard Hanna

Richard Hanna. From Wikipedia, the free encyclopedia. Jump to: navigation, search. Richard Hanna may refer to: U.S. Rep. Richard T. Hanna (D-Cal. ...

Us Patents

Methods And Uses Of Nur77 And Nur77 Agonists To Modulate Macrophages And Monocytes, And Treat Inflammation, Inflammatory Disease And Cardiovascular Disease

US Patent:
2013010, May 2, 2013
Filed:
Oct 5, 2012
Appl. No.:
13/646183
Inventors:
LA JOLLA INSTITUTE FOR ALLERGY AND IMMU - La Jolla CA, US
Klaus Ley - La Jolla CA, US
Richard Hanna - San Diego CA, US
Iftach Shaked - San Diego CA, US
Assignee:
LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY - La Jolla CA
International Classification:
A61K 38/17
A61K 31/404
A61K 31/235
A61K 35/14
US Classification:
424 9371, 514 212, 514 166, 514 17, 514 164, 514 154, 514 186, 514 177, 514 132, 514 183, 514415, 514545
Abstract:
Methods of decreasing, reducing, inhibiting, suppressing, limiting or controlling an undesirable or aberrant immune response, immune disorder, inflammatory response, or inflammation in a subject; decreasing, reducing, inhibiting, suppressing, limiting or controlling an autoimmune response, disorder or disease in a subject; and decreasing, reducing, inhibiting, suppressing, limiting or controlling an adverse cardiovascular event or cardiovascular disease in a subject, are provided. Methods include, for example, administering a Nur77 polypeptide or subsequence thereof, a Nur77 agonist, or CD14CD16monocytes or CD14CD16(CD115CD11bGR1 (Ly6C−)) monocytes or macrophages to a subject to decrease, reduce, inhibit, suppress, limit or control the underlying condition or an adverse symptom or pathology of the condition.

Monocyte Modulation And Control Of Tumor Metastasis

US Patent:
2021034, Nov 4, 2021
Filed:
Jul 6, 2021
Appl. No.:
17/368706
Inventors:
- La Jolla CA, US
Richard HANNA - San Diego CA, US
International Classification:
C07K 14/705
A61K 35/15
A61K 38/17
A61K 31/704
A61K 38/19
A61K 47/68
A61P 35/04
A61P 35/00
A61K 39/395
A61K 45/06
A61K 47/02
C07K 16/24
C07K 16/28
Abstract:
Disclosed herein are methods of increasing numbers of monocytes to a tumor or cancer metastasis site in a subject. Non-limiting embodiments include administering or using a Nur77 polypeptide or subsequence thereof; a Nur77 agonist; a CX3CR1 agonist; CD14CD16 monocytes and/or CD14CD16 (CD115CD11bGR1 (Ly6C−)) monocytes; CD14CD16 monocytes and/or CD14CD16 (CD115CD11bGR1 (Ly6C−)) monocytes contacted with a Nur77 agonist or contacted with a CX3CR1 agonist. Also disclosed herein are methods of increasing, stimulating, activating or promoting monocyte migration to or mobilization against a tumor or cancer metastasis in a subject. Non-limiting embodiments include administering a Nur77 polypeptide or subsequence thereof; a Nur77 agonist; a CX3CR1 agonist; CD14CD16 monocytes and/or CD14CD16 (CD115CD11bGR1 (Ly6C−)) monocytes; or CD14CD16 monocytes and/or CD14CD16 (CD115CD111bGR1 (Ly6C−)) monocytes contacted with a Nur77 agonist or contacted with a CX3CR1 agonist.

Monocyte Modulation And Control Of Tumor Metastasis

US Patent:
2018031, Nov 1, 2018
Filed:
Oct 27, 2016
Appl. No.:
15/772388
Inventors:
- La Jolla CA, US
Richard HANNA - San Diego CA, US
Assignee:
La Jolla Institute for Allergy and Immunology - La Jolla CA
International Classification:
C07K 14/705
C07K 16/24
C07K 16/28
A61K 35/15
A61K 47/68
A61K 47/02
A61K 45/06
A61K 38/17
A61K 39/395
A61P 35/00
A61P 35/04
Abstract:
Disclosed herein are methods of increasing numbers of monocytes to a tumor or cancer metastasis site in a subject. Non-limiting embodiments include administering or using a Nur77 polypeptide or subsequence thereof; a Nur77 agonist; a CX3CR1 agonist; CD14+ CD16 monocytes and/or CD14dimCD16(CD115CD11bGR1(Ly6C−)) monocytes; CD14CD16 monocytes and/or CD14dimCD16(CD115CD11bGR1(Ly6C−)) monocytes contacted with a Nur77 agonist or contacted with a CX3CR1 agonist. Also disclosed herein are methods of increasing, stimulating, activating or promoting monocyte migration to or mobilization against a tumor or cancer metastasis in a subject. Non-limiting embodiments include administering a Nur77 polypeptide or sub-sequence thereof; a Nur77 agonist; a CX3CR1 agonist; CD14+ CD16+ monocytes and/or CD14dimCD16(CD115CD11bGR1 (Ly6C−)) monocytes; or CD14CD16 monocytes and/or CD14dimCD16(CD115CD11bGR1(Ly6C−)) monocytes contacted with a Nur77 agonist or contacted with a CX3CR1 agonist.

Isbn (Books And Publications)

Fichtean Dynamic Of Novalis Poetics

Author:
Richard W. Hanna
ISBN #:
3261049545

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.